Novo Nordisk (NVO) faces a class action suit over claims it ran a pay-for-delay deal with Teva (TEVA) to delay generics for its diabetes drug.
https://seekingalpha.com/news/4542260-novo-sued-teva-deal-delay-generic-victoza
Novo Nordisk (NVO) faces a class action suit over claims it ran a pay-for-delay deal with Teva (TEVA) to delay generics for its diabetes drug.
https://seekingalpha.com/news/4542260-novo-sued-teva-deal-delay-generic-victoza
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.